Vanguard Portfolio Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$20.1M Sell
5,063,802
-449,553
-8% -$1.88M ﹤0.01% 1953
2026
Q2
$23.2M Sell
5,513,355
-1,168,682
-17% -$4.5M ﹤0.01% 1937
2026
Q1
$23.5M Buy
+6,682,037
New +$27.4M ﹤0.01% 1852

Other funds holding IRWD

Vanguard Portfolio Management's IRWD Position: Q3 2026 in Review

Vanguard Portfolio Management reduced its Ironwood Pharmaceuticals (IRWD) stake by 8.2% in Q3 2026, selling an estimated $1.88M and leaving 5,063,802 shares worth $20.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1953.

Vanguard Portfolio Management first reported a position in IRWD in Q1 2026 and has held it in 3 quarters since. The position peaked at $23.5M in Q1 2026. 233 funds tracked by Wall St. Rank hold IRWD as of Q3 2026.

  • Vanguard Portfolio Management held 5,063,802 shares of Ironwood Pharmaceuticals worth $20.1M as of Q3 2026.
  • Vanguard Portfolio Management sold 449,553 Ironwood Pharmaceuticals shares in Q3 2026, an estimated $1.88M.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q3 2026, its #1953 holding.
  • Vanguard Portfolio Management first reported a position in Ironwood Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Portfolio Management's Ironwood Pharmaceuticals position peaked at $23.5M in Q1 2026.
  • 233 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2026.

Based on Vanguard Portfolio Management's 13F filing for Q3 2026, filed 13 Nov 2026.